South African President Cyril Ramaphosa (L) and founder of NantWorks Patrick Soon-Shiong, right, cut the ribbon during the launch of NantSA, the future vaccine manufacturing campus in Brackengate, Cape Town, South Africa (Gianluigi Guercia/Pool Photo via AP)

Covid-19 man­u­fac­tur­ing roundup: New pro­duc­tion site opens in Africa; Sen­a­tor calls for test prices to be slashed

It looks like do­mes­tic man­u­fac­tur­ing of Covid-19 vac­cines is a step clos­er to re­al­i­ty for Africans af­ter a rib­bon cut­ting cer­e­mo­ny at the NantSA man­u­fac­tur­ing fa­cil­i­ty in Cape Town.

Patrick Soon-Sh­iong, a US bil­lion­aire who was born in South Africa, and Pres­i­dent Cyril Ramaphosa cut the rib­bon yes­ter­day at a plant large­ly fund­ed by Soon-Sh­iong.

“The COVID-19 pan­dem­ic has re­vealed the ex­tent of Africa’s health chal­lenges. The pan­dem­ic has re­vealed the huge dis­par­i­ties that ex­ist with­in and be­tween coun­tries in ac­cess to qual­i­ty health­care, med­i­cines, di­ag­nos­tics and vac­cines,” Ramaphosa said in a speech. “At the same time, the pan­dem­ic has re­vealed the depth of sci­en­tif­ic knowl­edge, ex­per­tise and ca­pac­i­ty on our con­ti­nent. It has shown what we are ca­pa­ble of when we work to­geth­er to mo­bi­lize all our re­sources to con­front a com­mon chal­lenge.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.